Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Malfunctioning Tumor Suppressor Genes Spur Growth of Liver Cancer

By LabMedica International staff writers
Posted on 24 Nov 2008
Cancer researchers have combined genomics, RNA interference, and mosaic mouse models to track down and identify a group of tumor suppressor genes that fails to operate in liver cancer cells.

Investigators at Cold Spring Harbor Laboratory (NY, USA) began by compiling pools of short hairpin RNAs (shRNAs) that specifically blocked the activity of the mouse orthologs of genes recurrently deleted in a series of human liver cancers. More...
Assuming that some of these shRNAs would inhibit tumor-suppressing genes, they tested the ability of the shRNAs to promote tumorigenesis in a mosaic mouse model.

They reported in the November 13, 2008, issue of the journal Cell that they had identified and validated 13 tumor suppressor genes, 12 of which had not been linked to cancer before. One gene, XPO4, encoded a nuclear export protein whose substrate, EIF5A2, was amplified in human tumors, was required for proliferation of XPO4-deficient tumor cells, and promoted liver cancer in mice.

"Apparently, there is a high incidence of cancer genes that are physically next to each other in the genome,” explained senior author Dr. Scott Lowe, professor of cellular and molecular biology at Cold Spring Harbor Laboratory. "It may explain why cancer is so heterogeneous; there are a lot of possible combinations to get there. It is important to understand all the genetic alterations that can give rise to cancer. If we understand cancer, we can treat it better by going after the molecular causes or by categorizing cancers to better predict their behavior.”

Related Links:
Cold Spring Harbor Laboratory



Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.